The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Status:
Recruiting
Trial end date:
2029-05-30
Target enrollment:
Participant gender:
Summary
To observe and evaluate the safety and effectiveness of Palonosetron hydrochloride capsule in
preventing acute nausea and vomiting caused by moderate emetic chemotherapy; The
characteristics of the applicable population, clinical medication and clinical benefits of
Palonosetron Hydrochloride Capsules were analyzed.